HealthWarehouse.com, Inc. HEWA OTC

Other OTC • Healthcare • Medical - Pharmaceuticals • US • USD

SharesGrow Score

40/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

HealthWarehouse.com, Inc. (HEWA) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 38/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

40/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

25/100

→ Income

✗

HEALTH

25/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

21/100

→ Income

✓

GROWTH

100/100

→ Income

✗

INCOME

30/100

→ Income

Valuation Snapshot — HEWA

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.12

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.00

Book Value / Share$0.00

Revenue / Share$0.87

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2016	$-0.04	$10.38M	$-1.41M	-13.6%
2017	$0.01	$14.85M	$371.78K	2.5%
2018	$-0.02	$15.75M	$-817.05K	-5.2%
2019	$0.00	$15.76M	$-99.4K	-0.6%
2020	$0.01	$17.18M	$441.78K	2.6%
2021	$-0.01	$16.14M	$-572.5K	-3.5%
2022	$-0.02	$18.14M	$-952.03K	-5.2%
2023	$-0.04	$20.28M	$-1.77M	-8.7%
2024	$-0.01	$33.61M	$-332.97K	-1%
2025	$0.00	$48.99M	$265K	0.5%